NCT06308679View on ClinicalTrials.gov

A Bioequivalence Study of Two Formulations of 10-mg Empagliflozin Tablets in Healthy Thai Volunteers Under Fasting Conditions

PHASE1Not yet recruitingINTERVENTIONAL
Enrollment

28

Participants

Timeline

Start Date

May 28, 2024

Primary Completion Date

May 31, 2024

Study Completion Date

June 7, 2024

Conditions
Healthy Vollunteer
Interventions
DRUG

Empagliflozin 10 mg tablets

Empagliflozin 10 mg tablets (test drug)

DRUG

JARDIANCE®

Empagliflozin 10 mg tablets (reference drug)

Sponsors

Lead Sponsor

Pharma Nueva
All Listed Sponsors
lead

Pharma Nueva

INDUSTRY

NCT06308679 - A Bioequivalence Study of Two Formulations of 10-mg Empagliflozin Tablets in Healthy Thai Volunteers Under Fasting Conditions | Biotech Hunter | Biotech Hunter